Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2014 Mar 27;20(7):992–999. doi: 10.1016/j.bbmt.2014.03.018

Figure 2.

Figure 2

Differences in JCV-specific CD4+ and CD8+ T cells responses in patients with or without viremia.

a.) JCV-specific CD4+ T cells significantly increased in the JC viremic subgroup at 12-18 months as compared to the same group at 6 months after transplantation.

b.) JCV-specific CD8+ T cells in the no JC viremia group at 12-18 months was higher than the same group at 3 months after transplantation.

c.) ELISpot demonstrated a significantly elevated T cell response in the subgroup without JCV viremia at the pre transplant time point as compared to those with JCV viremia.